PhoreMost, a UK-based biopharmaceutical company, has formed separate partnerships with Polaris Quantum Biotech (POLARISqb), a US-based quantum computing drug design company, and NeoCura Bio-Medical Technology (NeoCura), an RNA-based drug research and development company headquartered in China, to study and discover new oncology therapies.

Read more here.